Archives

by in
Entry Author Date Location
Alnylam Lays Out 2015 Goals 01/06/11 Boston
How Michael French, a Military Brat Turned Dealmaker, Kept Marina Biotech Alive 12/20/10 Seattle
Alnylam CEO Looks to the Future, Dicerna Plumps Up Kyowa Hakko Pact, Momenta Sells $57.4M Stock Offering, & More Boston-Area Life Sciences News 12/10/10 Boston
Alnylam CEO John Maraganore On Corporate Near-Termism, and Restoring Faith in RNAi 12/06/10 Boston
NanoBio Nabs $6M from Gates Foundation for Nasal Spray Vaccine 11/30/10 Detroit
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News 11/19/10 Boston
Dendreon Survives Medicare Panel, Arch’s Ouch, RNAi Shock Wave Hits Tekmira, & More Seattle-Area Life Sciences News 11/18/10 Seattle
Roche Cuts to Hit Hundreds of Genentech Workers; Scientific Staff is Spared 11/17/10 San Francisco
Roche Dumps RNAi, Sends Shock Waves Through Alnylam, Tekmira 11/17/10 National
Biogen Idec Chief Aims to Make Firm More Like Biotech and Less Like Pharma with Restructuring Plan 11/04/10 Boston
Trimble Scoops Up ThingMagic, Resolvyx Sells Option to Celtic Therapeutics, GSK Venture Arm Puts $4M into Dicerna, & More Boston-Area Deals News 10/27/10 Boston
ATyr Pharma Pockets $23M to Create New Class of Protein Drugs, and New Targets 10/26/10 San Diego
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Dicerna Gets Glaxo’s SR One to Join Investor Syndicate 10/21/10 Boston
Alnylam Seeks to Prove RNAi Skeptics Wrong After Layoffs, End of Novartis Deal 10/21/10 Boston
5 Biotech Storylines to Watch in Boston 10/13/10 Boston
ProNAi Therapeutics Advances Gene-Silencing Cancer Drug, Marina Biotech Provides Delivery Package 09/28/10 Detroit
Alnylam Cuts 25-30% of Workforce, As Novartis Alliance Ends 09/23/10 Boston
Former Sirtris Execs Sell Resveratrol Via New Nonprofit, Dicerna Closes $25M Deal, ViThera Combats Gut Disease With Engineered Bacteria, & More Boston-Area Life Sciences News 08/13/10 Boston
Dicerna Pharma Gets $25M Boost to Develop Next-Gen Gene Silencing Drugs 08/11/10 Boston
Marina Gets RNAi Delivery Tools for $5M 07/28/10 Seattle
Tekmira Nails $140M Defense Contract to Make RNAi Drug for Ebola 07/15/10 Seattle
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology 07/15/10 Boston
Drop the Incrementalism & More Advice on How to Create a Stable Hub for Innovation 07/02/10 San Francisco
Former J&J Group Chairman’s Firm Backs BIND Biosciences in $12.4M Round 06/29/10 Boston
Third Rock Invests in Ablexis, Acceleron Grabs $8.4M, Alnylam Chief Joins Agios Board, & More Boston-Area Life Sciences News 06/25/10 Boston
Regulus Therapeutics, Spinoff of Isis and Alnylam, Forms $750M MicroRNA Deal With Sanofi 06/22/10 San Diego
Polaris Raises $234M for New Fund, BioScale Pins Down $25M, Clinical Data Nets $30M, & More Boston-Area Deals News 06/16/10 Boston
Modumetal Closes Series B, TerraPower Pulls In $35M, Vertafore Bought for $1.4B, & More Seattle-Area Deals News 06/15/10 Seattle
Polaris Venture Partners Captures $233M of $400M Fund 06/14/10 Boston
Page 3 of 8 « previous page · next page »